nanotechnology-smart-materials-2018-tracks

E u r o S c i C o n C o n f e r e n c e o n

Nanotechnology &

Smart Materials

Nano Research & Applications

ISSN 2471-9838

O c t o b e r 0 4 - 0 6 , 2 0 1 8

Am s t e r d a m , N e t h e r l a n d s

Nanotechnology & Smart Materials 2018

Page 34

anomedicine, the convergence between nanotechnology and medical

application, is a hot field. Many research groups all around the world focus

their efforts on the invention of potential new nanomaterials that can contribute

to improved health care. The nanoscale physical properties of these particles

afford a unique potential for biomedical application in the treatment of e.g. cancer,

brain, inflammatory and immune diseases. Despite their great potential, the far

majority of all discovered nanomedicines are still at the research stage. To bring

the discovery from laboratory bench to patient bedside requires a whole different

discipline: pharmaceutical development. This presentation will give the audience

a sneak peek of what it takes to navigate a potential nanomedicine through the

world of drug development. Special attention will be given to the translation from

lab experiments to production of nanomedicine intended for use in humans

Biography

Silvie A Meeuwissen has received a PhD in Bioorganic Chem-

istry from Radboud University in Nijmegen, under the supervi-

sion of Prof Jan van Hest in 2013. Her research is focussed on

polymer chemistry and the creation, analysis and application of

nanocarriers. She worked on a Postdoctoral project at Future

Chemistry in cooperation with the Synthetic Organic Chemistry

Group of Prof Floris Rutjes (RU Nijmegen), before she started

as a Researcher at ChemConnection in 2014. ChemConnec-

tion, part of the Ardena group, is a contractor for all chemical,

pharmaceutical and bioanalytical needs that arise in the clinical

supply chain from lab to patient. Currently, she is working as a

Principal Scientist and manages several projects, focusing on

process development and GMP manufacture of novel nano-

medicine candidates for preclinical trials.

GMP manufacturing of nanomedicines for

clinical trials

Silvie A Meeuwissen

Ardena-ChemConnection B V, The Netherlands

Silvie A Meeuwissen, Nano Res Appl Volume:4

DOI: 10.21767/2471-9838-C6-024